invoX Pharma Limited
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| FS222 First in Human Study in Patients With Advanced Malignancies (NCT04740424) | invoX Pharma Limited | 2020-12-14 |
| FS120 Phase 1/1b Study in Patients With Advanced Malignancies (NCT04648202) | invoX Pharma Limited | 2020-11-18 |
| Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors (NCT04096638) | invoX Pharma Limited | 2019-09-23 |
| A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies (NCT03440437) | invoX Pharma Limited | 2018-04-16 |
Track invoX Pharma Limited automatically
Every clearance here is in the API, with alerts when new ones post.